Bridging bioengineering and epigenetics: from technical innovations to clinical applications

Abstract The 7th International Conference on Epigenetics & Bioengineering held in Amsterdam, The Netherlands was a successful event covering cutting-edge research utilizing innovative technologies from multidisciplinary international scientists in the fields of epigenetics and bioengineering, wi...

Full description

Saved in:
Bibliographic Details
Main Authors: Jim Jacob, Quint C. van Loosen, Anna C. H. van den Berg van Saparoea, Federica Sarno, Pernette J. Verschure
Format: Article
Language:English
Published: BMC 2024-12-01
Series:Epigenetics Communications
Subjects:
Online Access:https://doi.org/10.1186/s43682-024-00031-x
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846101427322093568
author Jim Jacob
Quint C. van Loosen
Anna C. H. van den Berg van Saparoea
Federica Sarno
Pernette J. Verschure
author_facet Jim Jacob
Quint C. van Loosen
Anna C. H. van den Berg van Saparoea
Federica Sarno
Pernette J. Verschure
author_sort Jim Jacob
collection DOAJ
description Abstract The 7th International Conference on Epigenetics & Bioengineering held in Amsterdam, The Netherlands was a successful event covering cutting-edge research utilizing innovative technologies from multidisciplinary international scientists in the fields of epigenetics and bioengineering, with an emphasis on development and disease. This conference report highlights the outstanding research presented and the engaging discussions that took place. Throughout the sessions, leading experts demonstrated novel technologies to explore epigenetic mechanisms, including advanced data analysis pipelines and bioengineered systems. Several speakers uncovered emerging fundamental principles and demonstrated how these insights are being applied to address (bio)medical challenges, underscoring that the field is progressing toward (pre)clinical applications of targeted epigenetic therapies. The conference featured stimulating discussions on the causal relationship between epigenetic marks and transcription, emphasizing the importance of standardizing epigenetic editing methodologies.
format Article
id doaj-art-a24e015310d44a2bbd9c2d9af3b5beff
institution Kabale University
issn 2730-7034
language English
publishDate 2024-12-01
publisher BMC
record_format Article
series Epigenetics Communications
spelling doaj-art-a24e015310d44a2bbd9c2d9af3b5beff2024-12-29T12:11:11ZengBMCEpigenetics Communications2730-70342024-12-01411910.1186/s43682-024-00031-xBridging bioengineering and epigenetics: from technical innovations to clinical applicationsJim Jacob0Quint C. van Loosen1Anna C. H. van den Berg van Saparoea2Federica Sarno3Pernette J. Verschure4Epigenetic Editing Research Group, Department of Pathology and Medical Biology, University Medical Center GroningenMolecular and Cellular Epigenetics Group, Swammerdam Institute for Life Sciences, University of AmsterdamMolecular and Cellular Epigenetics Group, Swammerdam Institute for Life Sciences, University of AmsterdamEpigenetic Editing Research Group, Department of Pathology and Medical Biology, University Medical Center GroningenMolecular and Cellular Epigenetics Group, Swammerdam Institute for Life Sciences, University of AmsterdamAbstract The 7th International Conference on Epigenetics & Bioengineering held in Amsterdam, The Netherlands was a successful event covering cutting-edge research utilizing innovative technologies from multidisciplinary international scientists in the fields of epigenetics and bioengineering, with an emphasis on development and disease. This conference report highlights the outstanding research presented and the engaging discussions that took place. Throughout the sessions, leading experts demonstrated novel technologies to explore epigenetic mechanisms, including advanced data analysis pipelines and bioengineered systems. Several speakers uncovered emerging fundamental principles and demonstrated how these insights are being applied to address (bio)medical challenges, underscoring that the field is progressing toward (pre)clinical applications of targeted epigenetic therapies. The conference featured stimulating discussions on the causal relationship between epigenetic marks and transcription, emphasizing the importance of standardizing epigenetic editing methodologies.https://doi.org/10.1186/s43682-024-00031-xEpigeneticsBioengineeringEmerging technologiesChromatin organizationGene regulationBiomedical applications
spellingShingle Jim Jacob
Quint C. van Loosen
Anna C. H. van den Berg van Saparoea
Federica Sarno
Pernette J. Verschure
Bridging bioengineering and epigenetics: from technical innovations to clinical applications
Epigenetics Communications
Epigenetics
Bioengineering
Emerging technologies
Chromatin organization
Gene regulation
Biomedical applications
title Bridging bioengineering and epigenetics: from technical innovations to clinical applications
title_full Bridging bioengineering and epigenetics: from technical innovations to clinical applications
title_fullStr Bridging bioengineering and epigenetics: from technical innovations to clinical applications
title_full_unstemmed Bridging bioengineering and epigenetics: from technical innovations to clinical applications
title_short Bridging bioengineering and epigenetics: from technical innovations to clinical applications
title_sort bridging bioengineering and epigenetics from technical innovations to clinical applications
topic Epigenetics
Bioengineering
Emerging technologies
Chromatin organization
Gene regulation
Biomedical applications
url https://doi.org/10.1186/s43682-024-00031-x
work_keys_str_mv AT jimjacob bridgingbioengineeringandepigeneticsfromtechnicalinnovationstoclinicalapplications
AT quintcvanloosen bridgingbioengineeringandepigeneticsfromtechnicalinnovationstoclinicalapplications
AT annachvandenbergvansaparoea bridgingbioengineeringandepigeneticsfromtechnicalinnovationstoclinicalapplications
AT federicasarno bridgingbioengineeringandepigeneticsfromtechnicalinnovationstoclinicalapplications
AT pernettejverschure bridgingbioengineeringandepigeneticsfromtechnicalinnovationstoclinicalapplications